Medbytes Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 1 Year 9 Months
- Last Filing with ROC 31 Mar 2024
About Medbytes Pharma
Medbytes Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 19 April 2023 (One year and nine months 21 days old ). Its registered office is in Sangli, Maharashtra, India.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Durgade, Lalit Shah, and Neha Shah serve as directors at the Company.
Company Details
-
Location
Sangli, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U47721PN2023PTC219731
-
Company No.
219731
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
19 Apr 2023
-
Date of AGM
30 Nov 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Pune
Who are the key members and board of directors at Medbytes Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Durgade
|
Director | 01-Aug-2023 | Current |
|
Lalit Shah
|
Director | 19-Apr-2023 | Current |
|
Neha Shah
|
Director | 19-Apr-2023 | Current |
Financial Performance of Medbytes Pharma.
Enhance accessibility to Medbytes Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medbytes Pharma?
Unlock access to Medbytes Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Azalea Biotec Private LimitedVishal Durgade is a mutual person
-
Eleazar Clinical Pharmacy LlpVishal Durgade is a mutual person
-
Shivflex Pipes Private Limited
Vishal Durgade is a mutual person
-
Vbd Consultancy Services Llp
Lalit Shah is a mutual person
-
Koala Pharmacy & Infra Llp
Lalit Shah and Neha Shah are mutual person
-
Malasa Constrochem Industries Private Limited
Lalit Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medbytes Pharma?
Unlock and access historical data on people associated with Medbytes Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medbytes Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medbytes Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.